Expertise in
17
conditions

Dr. Namasivayam Ambalavanan

Neonatology
Office
1700 6th Ave S Ste 9380, 
Birmingham, AL 
Accepting New Patients
Expertise in
17
conditions
Office
1700 6th Ave S Ste 9380, 
Birmingham, AL 

Overview

Namasivayam Ambalavanan is a Neonatologist practicing medicine in Birmingham, Alabama.

Dr. Ambalavanan is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Bronchopulmonary Dysplasia, Premature Infant, High Blood Pressure in Infants, Infantile Apnea, and Gastrostomy.

He is actively involved in clinical research, co-authoring 337 peer reviewed articles and participating in 7 clinical trials. Dr. Ambalavanan is currently accepting new patients.

Specialties

Neonatology

Licenses

Pediatrics in AL

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
View 1 Less Insurance Carrier -

Locations

Office
1700 6th Ave S Ste 9380, Birmingham, AL 35233

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Pragmatic, Randomized, Blinded Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
Pragmatic, Randomized, Blinded Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
Enrollment Status: Active_not_recruiting
Publish Date: June 30, 2026
Intervention Type: Drug
Study Drugs: Morphine, Methadone
Study Phase: Phase 3
Cardboard Cot in Neonatal Thermoregulation: Prevention of Moderate or Severe Hypothermia in Preterm Infants Assigned to Open Crib
Cardboard Cot in Neonatal Thermoregulation: Prevention of Moderate or Severe Hypothermia in Preterm Infants Assigned to Open Crib
Enrollment Status: Withdrawn
Publish Date: October 26, 2021
Intervention Type: Other
Study Phase: Not Applicable
Cardboard Cot in Neonatal Thermoregulation: A Randomized Cross Over Trial in Prevention of Moderate or Severe Hypothermia in Preterm Infants Requiring at Least 1 Week of Incubator
Cardboard Cot in Neonatal Thermoregulation: A Randomized Cross Over Trial in Prevention of Moderate or Severe Hypothermia in Preterm Infants Requiring at Least 1 Week of Incubator
Enrollment Status: Withdrawn
Publish Date: October 26, 2021
Intervention Type: Other
Study Phase: Not Applicable
Prematurity-Related Ventilatory Control (PRE-VENT): Role in Respiratory Outcomes Clinical Research Centers (CRC) - Specific Aim 3
Prematurity-Related Ventilatory Control (PRE-VENT): Role in Respiratory Outcomes Clinical Research Centers (CRC) - Specific Aim 3
Enrollment Status: Completed
Publish Date: September 21, 2021
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Prematurity-Related Ventilatory Control (PRE-VENT): Role in Respiratory Outcomes Clinical Research Centers (CRC)
Prematurity-Related Ventilatory Control (PRE-VENT): Role in Respiratory Outcomes Clinical Research Centers (CRC)
Enrollment Status: Completed
Publish Date: September 21, 2021
Intervention Type: Diagnostic test
Study Phase: Not Applicable
A Phase IIb Randomized, Placebo-controlled, Double-blind Trial of Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants
A Phase IIb Randomized, Placebo-controlled, Double-blind Trial of Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants
Enrollment Status: Completed
Publish Date: November 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
Cerebral Oxygenation and Autoregulation in Preterm Infants: Association With Morbidity and Mortality
Cerebral Oxygenation and Autoregulation in Preterm Infants: Association With Morbidity and Mortality
Enrollment Status: Completed
Publish Date: April 07, 2020
Intervention Type: Device
View 6 Less Clinical Trials

337 Total Publications

Limbic System Microstructure in Neonates With Antenatal Opioid Exposure.
Limbic System Microstructure in Neonates With Antenatal Opioid Exposure.
Journal: JAMA network open
Published: July 02, 2026
Similar Doctors
Expertise in
15
conditions
Expertise in
15
conditions
Referral may be required

Office

1700 6th Ave S Ste 9380, 
Birmingham, AL 
 (0.1 miles away)
205-996-2244
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Waldemar Carlo is a Neonatologist practicing medicine in Birmingham, Alabama. Dr. Carlo is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Premature Infant, Bronchopulmonary Dysplasia, Infant Respiratory Distress Syndrome, and Infantile Apnea. Dr. Carlo is currently accepting new patients.

Expertise in
9
conditions
Dr. Colm P. Travers
Neonatology | Pediatrics
Expertise in
9
conditions
Dr. Colm P. Travers
Neonatology | Pediatrics
Referral may be required

UAB Women And Infants Center

1700 6th Ave S, 
Birmingham, AL 
 (0.2 miles away)
205-934-4680
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Colm Travers is a Neonatologist and a Pediatrics provider practicing medicine in Birmingham, Alabama. Dr. Travers is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Premature Infant, Infantile Apnea, Bronchopulmonary Dysplasia, and Cerebral Hypoxia. Dr. Travers is currently accepting new patients.

Expertise in
7
conditions
Dr. Ashley N. Battarbee
Neonatology | Obstetrics and Gynecology
Expertise in
7
conditions
Dr. Ashley N. Battarbee
Neonatology | Obstetrics and Gynecology
Referral may be required
Before you request

UAB Women And Infants Center

1700 6th Ave S, 
Birmingham, AL 
 (0.2 miles away)
800-822-8816
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ashley Battarbee is a Neonatologist and an Obstetrics and Gynecologist practicing medicine in Birmingham, Alabama. Dr. Battarbee is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Newborn Low Blood Sugar, Gestational Diabetes, Intraventricular Hemorrhage of the Newborn, and Infant Respiratory Distress Syndrome. Dr. Battarbee is currently accepting new patients.

Frequently Asked Questions about Dr. Namasivayam Ambalavanan

How do I make an appointment with Dr. Namasivayam Ambalavanan?

You can book an appointment with Dr. Namasivayam Ambalavanan by calling their office at 205-934-4680. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Namasivayam Ambalavanan a top-rated expert for Bronchopulmonary Dysplasia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Namasivayam Ambalavanan is classified as an Elite expert for Bronchopulmonary Dysplasia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Namasivayam Ambalavanan specialize in?

While Dr. Namasivayam Ambalavanan is a Neonatology, they have specific expertise in Bronchopulmonary Dysplasia, Premature Infant, and High Blood Pressure in Infants. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neonatology.

Does Dr. Namasivayam Ambalavanan participate in research or clinical trials?

Yes. Dr. Namasivayam Ambalavanan has published 337 articles and abstracts on conditions like Bronchopulmonary Dysplasia. You can view a list of Dr. Namasivayam Ambalavanan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Namasivayam Ambalavanan accept my insurance?

Dr. Namasivayam Ambalavanan accepts most major insurance plans, including Blue Cross Blue Shield and Cigna. We recommend calling the office directly at 205-934-4680 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ambalavanan's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile